AG 957
AG 957 Basic information
- Product Name:
- AG 957
- Synonyms:
-
- METHYL-4-[N-(2',5'-DIHYDROXYBENZYL)AMINO]BENZOATE
- LAVENDUSTIN C ANALOG
- 4-AMINO-N-(2,5-DIHYDROXYBENZYL)METHYL BENZOATE
- AG 957
- TYRPHOSTIN AG 957
- TYRPHOSTIN 957
- NSC 654705
- Lavendustin C Analog, Methyl-4-[N-(2μ,5μ-dihydroxybenzyl)amino]benzoate
- CAS:
- 140674-76-6
- MF:
- C15H15NO4
- MW:
- 273.28
- Mol File:
- Mol File
AG 957 Chemical Properties
- Boiling point:
- 504.2±45.0 °C(Predicted)
- Density
- 1.337±0.06 g/cm3(Predicted)
- storage temp.
- −20°C
- solubility
- DMSO: soluble
- form
- crystalline solid
- pka
- 10.30±0.43(Predicted)
- color
- Off-white to light brown
Safety Information
- Safety Statements
- 22-24/25
- WGK Germany
- 3
MSDS
- Language:English Provider:SigmaAldrich
AG 957 Usage And Synthesis
Description
Tyrphostins are tyrosine phosphorylation inhibitors that act by inhibiting tyrosine kinases. AG957 is a tyrphostin that targets transforming Bcr-Abl fusion proteins (p185Bcr-Abl, p210Bcr-Abl), as well as normal c-Abl (IC50s = 4.3, 1, and 7.1 μM, respectively, for human proteins). It also inhibits epidermal growth factor receptor (IC50 = 0.25 μM). As the constitutively-active 210 kDa Bcr-Abl fusion protein commonly occurs in chronic myelogenous leukemia (CML) cells, AG957 is commonly used to study Bcr-Abl signaling in the CML K562 cell line. AG957 is also used to study signaling through c-Abl.
Uses
Tyrphostin AG 957 is a potent tyrosine kinase inhibitor. Also, it causes metabolic alterations in K562 cells. It is a COVID19-related research product.
Definition
ChEBI: 4-[(2,5-dihydroxyphenyl)methylamino]benzoic acid methyl ester is an aromatic amine.
References
[1]. anafi m, gazit a, gilon c, et al. selective interactions of transforming and normal abl proteins with atp, tyrosine-copolymer substrates, and tyrphostins. j biol chem. 1992 mar 5;267(7):4518-23.
[2]. kaur g, gazit a, levitzki a, et al. tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in k562 chronic myelogenous leukemia. anticancer drugs. 1994 apr;5(2):213-22.
[3]. jamieson l, carpenter l, biden tj, et al. protein kinase ciota activity is necessary for bcr-abl-mediated resistance to drug-induced apoptosis. j biol chem. 1999 feb 12;274(7):3927-30.
[4]. fu p, usatyuk pv, lele a, et al. c-abl mediated tyrosine phosphorylation of paxillin regulates lps-induced endothelial dysfunction and lung injury. am j physiol lung cell mol physiol. 2015 may 15;308(10):l1025-38.
AG 957Supplier
- Tel
- 021-021-021-67601398-809-809-809 15221380277
- marketing_china@spectrumchemical.com
- Tel
- 025-66099280 17798518460
- cfzhang@aikonchem.com
- Tel
- +1 (866) 930-6790
- info@adooq.com
- Tel
- 16314854226
- info@bocsci.com
- Tel
- 021-80270511; 4006653949
- fred.wen@crcorporation.cn